We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+3.76%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$910M
AUM Growth
-$281M
Cap. Flow
-$283M
Cap. Flow %
-31.16%
Top 10 Hldgs %
40.89%
Holding
141
New
25
Increased
18
Reduced
31
Closed
51

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$27.6M
2
AMZN icon
Amazon
AMZN
+$13.8M
3
FIVN icon
FIVE9
FIVN
+$12.7M
4
SNY icon
Sanofi
SNY
+$11.9M
5
S icon
SentinelOne
S
+$11.7M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$47.9M
2
PFE icon
Pfizer
PFE
+$43.5M
3
ABBV icon
AbbVie
ABBV
+$15.6M
4
AZN icon
AstraZeneca
AZN
+$13.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 68.66%
2 Technology 9.03%
3 Consumer Discretionary 4.71%
4 Communication Services 2.8%
5 Industrials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDNY
76
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.82M 0.2%
+111,653
New +$1.59M
LIAN
77
DELISTED
LianBio American Depositary Shares
LIAN
$1.66M 0.18%
+275,007
New +$3.14M
ARGX icon
78
argenx
ARGX
$53.4B
$1.5M 0.17%
4,291
-4,958
-54% -$1.51M
ANNX icon
79
Annexon
ANNX
$834M
$1.42M 0.16%
123,637
– –
DYN icon
80
Dyne Therapeutics
DYN
$4.7B
$1.25M 0.14%
105,204
-119,879
-53% -$1.68M
MGIC
81
DELISTED
Magic Software Enterprises
MGIC
$1.21M 0.13%
57,704
– –
CYT
82
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$1.12M 0.12%
98,860
-36,285
-27% -$553K
ARBE icon
83
Arbe Robotics
ARBE
$80.3M
$1.12M 0.12%
+120,400
New +$1.23M
VRTX icon
84
Vertex Pharmaceuticals
VRTX
$121B
$969K 0.11%
+4,411
New +$858K
LVTX
85
DELISTED
LAVA Therapeutics
LVTX
$758K 0.08%
137,857
-77,502
-36% -$508K
IMTXW
86
DELISTED
Immatics N.V. Warrants
IMTXW
$439K 0.05%
100,000
– –
OTLKW
87
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$15K ﹤0.01%
129,500
– –
ACIU icon
88
AC Immune
ACIU
$223M
– –
-121,019
Closed -$812K
ADSK icon
89
Autodesk
ADSK
$49.5B
– –
-27,500
Closed -$7.84M
AFMD
90
DELISTED
Affimed
AFMD
– –
-111,762
Closed -$6.91M
ALGS icon
91
Aligos Therapeutics
ALGS
$26.2M
– –
-9,968
Closed -$3.87M
ALT icon
92
CALL
Altimmune
ALT
$552M
– –
-1,000,000
Closed -$11.3M
ALXO icon
93
ALX Oncology
ALXO
$261M
– –
-128,706
Closed -$9.51M
AMAT icon
94
Applied Materials
AMAT
$403B
– –
-14,500
Closed -$1.87M
AUDC icon
95
AudioCodes
AUDC
$244M
– –
-316,428
Closed -$10.3M
BIIB icon
96
CALL
Biogen
BIIB
$30B
– –
-50,000
Closed -$14.1M
BMY icon
97
CALL
Bristol-Myers Squibb
BMY
$133B
– –
-500,000
Closed -$29.6M
CALX icon
98
Calix
CALX
$2.26B
– –
-105,290
Closed -$5.2M
CRBU icon
99
Caribou Biosciences
CRBU
$145M
– –
-200,000
Closed -$4.77M
CVRX icon
100
CVRx
CVRX
$137M
– –
-150,000
Closed -$2.48M
2 3
4
5 6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sphera Funds Management held 141 positions worth $910M, down 24% from $1.19B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sphera Funds Management withdrew a net $283M in Q4 2021, closing 51 positions and reducing 31 holdings. Its most notable exit was SolarEdge, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Merck worth $26.6M.

  • Sphera Funds Management's largest Q4 2021 buy was Merck: 346,423 shares worth $26.6M.
  • Sphera Funds Management added most to Amazon in Q4 2021, an estimated $13.8M increase.
  • Sphera Funds Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $47.9M.
  • Sphera Funds Management fully exited SolarEdge in Q4 2021, selling an estimated $13.3M.
  • Sphera Funds Management's ten largest holdings make up 41% of its $910M portfolio in Q4 2021.
  • Sphera Funds Management opened 25 new positions and closed 51 in Q4 2021.
  • Sphera Funds Management's portfolio value fell 24% quarter-over-quarter to $910M.

Based on Sphera Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.